<?xml version="1.0" encoding="UTF-8"?>
<p>Darunavir is a second generation of HIV-1 protease inhibitors. It is a non-peptidic inhibitor of protease that enters itself in the active site of protease through several hydrogen bonds [
 <xref rid="B61-pathogens-09-00331" ref-type="bibr">61</xref>]. A recent report of an in vitro experiment indicated that using darunavir at a concentration of 300 Î¼M, significantly inhibits SARS-CoV-2 replication. Its inhibition efficiency increased by 280-fold in comparison to the control group [
 <xref rid="B44-pathogens-09-00331" ref-type="bibr">44</xref>].
</p>
